Researchers in Australia are creating 3D replicas of patient’s hearts to plan out left atrial appendage closures using Boston Scientific‘s (NYSE:BSX) Watchman device, according to a new report from heartwire. Creating the 3D replica is useful in patients with complicated cardiovascular anatomy, where even advanced imaging methods can make it difficult to quantify the area […]
Cardiovascular
Welcome to MassDevice's Cardiovascular Hub, your resource for the latest news in cardiac implants, structural heart, heart valves, stents and more. Stay informed about the innovations and business news shaping the cardiovascular device industry.
🫀 Narrow your focus with these categories:
Cardiac Implants | Structural Heart | Pulsed-Field Ablation
Here are top cardiology features from MassDevice and its sister publications (and scroll down to read the latest cardiology device news from MassDevice):
+ LVADs save lives: So why aren’t more available?
+ How Medtronic uses nitinol to improve the structure and effectiveness of heart devices
+ How Abbott designed the world’s first dual-chamber leadless pacemaker system
+ J&J used RWE for expanded indications — and you can, too
+ 7 cardiology startups you need to know
Latest Cardiology News
Study: Manual thrombectomy increases stroke risk
Routine percutaneous coronary interventions with manual thrombectomies increase the risk of stroke compared to PCI alone, according to a new substudy published last month. The substudy, published online already and set to go to print in the European Heart Journal, examined a 10,058-patient cohort from the earlier Total study of PCI and manual thrombectomies to […]
Boston Scientific launches resorbable stent trial
Boston Scientific (NYSE:BSX) said today that it launched a 30-patient study of its 1st fully resorbable drug-eluting stent, which is based on its Synergy device. Marlborough, Mass.-based Boston Scientific said the new stent uses a resorbable polymer with an ultrathin everolimus coating, technology it also used with the Synergy stent. “We are taking the best of our […]
OrbusNeich launches Chinese Combo stent trial
OrbusNeich said today it launched a Chinese trial of its Combo dual-therapy coronary stent designed to repair vessel injury and regenerate endothelium. The 436-patient randomized, non-inferiority trial has enrolled its 1st patient, the Hong Kong-based company said, and will compare the Combo stent’s effectiveness against Lepu Medical‘s Nano stent for up to 5 years. “We […]
Study challenges CABG mortality benefits over stenting
A new registry analysis study is challenging the benefits of coronary artery bypass grafting over percutaneous coronary interventions using everolimus-eluting stents in patients with diabetes mellitus and multivessel disease. Results from the 16,000+ patient analysis, published July 8 in Circulation: Cardiovascular Interventions, did not support previous results that suggested that CABG treatments resulted in lower mortality rates than […]
Indian diamond cutting industry gets into stents
Western Indian diamond cutting businesses are beginning to develop coronary stents, producing cheaper copies of stents made by market leaders, according to a report from Bloomberg Business. The companies, such as Surat-based Sahajanand Medical Technologies, are using existing laser-cutting technology necessary for diamond cutting to cut the metal tubes used in stents, according to the report. […]
Another stent better than DEB, DCB for in-stent restenosis, studies find
Treatment with another stent, rather than from a drug-coated or drug-eluting balloon, has been shown to be more effective in treating coronary in-stent restenosis, according to 2 new studies. The 2 studies, 1 European and 1 Japanese, were published in the Journal of the American College of Cardiology earlier this month. The 309-patient European Ribs […]
Aum Cardiovascular pulls in $5m
Aum Cardiovascular said in a regulatory filing that it raised $5 million of a hoped-for $6.3 million funding push for the Cadence handheld device it developed to detect heart disease. The Northfield, Minn.-based company was founded by CEO Marie Johnson after the unexpected death of her husband from a heart attack at age 41, according to Aum […]
Thoratec wins CE Mark for HeartMate PHP
Thoratec (NSDQ:THOR) said today it won CE Mark approval in the European Union for its HeartMate percutaneous heart pump. Approval was based on data from the 1st 30 patients enrolled in its Shield I CE mark trial, the Pleasanton, Calif.-based company said. Data from all 50 patients in the study is slated to be presented later this […]
Edwards Lifesciences to drop $400m on CardiAQ Valve
Edwards Lifesciences (NYSE:EW) last week said it agreed to pay $400 million for CardiAQ Valve Technologies and its transcatheter mitral valve implant, saying it also reached a deal to revise the protocol for restarting a trial of its own Fortis mitral valve. The deal for CardiAQ Valve, which like Edwards is based in Irvine, Calif., calls for an up-front […]
CryoLife BioGlue wins expanded indication in Japan
CryoLife Inc. (NYSE:CRY) said yesterday that it won expanded indications from the Japanese Pharmaceuticals and Medical Device Agency for its BioGlue surgical adhesive. The glue is now indicated for use in adhesion and support of hemostasis for aortotomy closure sites, suture and anastomosis sites (including aortic dissection and prosthetic grafts) and heart suture sites, the […]